Neosoma Brain Mets
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
Neosoma Brain Mets is AI software that segments and measures brain metastases on MRI to support tracking across scans; Neosoma also offers NS-HGlio for high-grade glioma.
- FDA:
- 510(k) K252922
- Epic:
- Not on record
- Named users:
- Not on record
- Published study:
- Not on record
Description
Neosoma Brain Mets is AI software that segments and measures brain metastases on MRI to support tracking across scans; Neosoma also offers NS-HGlio for high-grade glioma. FDA 510(k) K252922 (December 2025) and K221738.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Neosoma Brain Mets FDA cleared?
- The public FDA database has one record that our team matched to Neosoma Brain Mets. The most recent is 510(k) K252922 (Neosoma Brain Mets), decided Dec 2025. Check that the cleared use matches how you plan to use it.FDA record K252922
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
Organizations named in public announcements or by the developer. Inclusion is not an endorsement.
No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.
Get weekly updates for Neurology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteFDA database records
- K252922 · 510(k) · Dec 2025Neosoma Brain Mets
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (2)Show
Dated events on this listing's public record, newest first.
- Oct 31, 2026
Added to CIFoundry
- Dec 17, 2025
FDA 510(k) K252922 decision datesource
Developer
Neosoma
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →